Saffron for PMDD: does it work?

Saffron shows real promise for PMDD, but it rests on surprisingly little research.

The one trial testing saffron specifically for PMDD found it worked about as well as the SSRI fluoxetine (20mg twice daily), with fewer side effects (Advanced Biomedical Research, 2020). That result comes from a single study of 120 women over two cycles, not a body of repeated findings.

Most of what we know about saffron and mood actually comes from PMS and depression trials, not PMDD specifically. A systematic review of saffron trials on psychological outcomes found consistent positive effects, but called for larger trials before drawing firm conclusions (Journal of Integrative Medicine, 2015).

Wider reviews of saffron's effects on the brain also describe it as promising and well tolerated, though not yet proven at scale (Avicenna Journal of Phytomedicine, 2022). Saffron looks hopeful for PMDD, backed by one solid trial, but it hasn't been confirmed the way SSRIs or CBT have.

The strongest data point is a 2020 randomized trial of 120 women diagnosed with PMDD, published in Advanced Biomedical Research. Over two luteal-phase cycles, researchers compared saffron, fluoxetine and placebo.

Both saffron and fluoxetine produced similar drops in daily symptom (DRSP) scores; on the Hamilton depression measure, the three groups didn't differ significantly (P>0.05). Fluoxetine caused more side effects along the way, which is why researchers concluded saffron worked about as well with less burden.

Outside that one trial, the evidence is mostly about PMS, not PMDD. A meta-analysis of PMS trials found saffron reduced symptom severity by a solid margin, with a standardized mean difference of -0.64 (Korean Journal of Family Medicine, 2026).

A systematic review of saffron's effects on the female reproductive system reached a similar conclusion for PMS and related cycle symptoms (Phytotherapy Research, 2024). None of that is specific to PMDD, which is a distinct, more severe diagnosis, so it only tells us saffron likely helps mood tied to the cycle in general, not that it's confirmed for PMDD.

In the PMDD trial, participants took 15mg of standardized saffron extract twice daily, starting around two weeks before their expected period and continuing through that window, for two full cycles (Advanced Biomedical Research, 2020). That's the same two-weeks-on pattern used for luteal-phase SSRIs.

A few practical points if you're considering it:

• Trials use standardized extract capsules, not raw saffron threads or spice from the kitchen.
• Dosing matched the luteal phase only, not every day of the cycle.
• No higher dose has been shown safer or more effective than what was studied.

For a fuller breakdown of amounts, timing and what to look for on a label, see saffron dosage: how much and when.

Researchers in the PMDD trial measured results after two full luteal-phase courses, each two weeks long, so about two menstrual cycles in total (Advanced Biomedical Research, 2020). That's how long they waited before comparing scores, not proof that nothing happens sooner.

Saffron's broader mood research, including depression trials, usually measures change over several weeks of daily use, not days (Journal of Integrative Medicine, 2015). Two cycles is a reasonable minimum before deciding whether it's working for you.

If hard feelings show up before you've finished those two cycles, that doesn't mean it's failing. It means you're still in the window the research actually tested.

For a week-by-week sense of what to expect, see how long does saffron take to work.

Saffron's side effects are usually mild. In the PMDD trial, saffron caused significantly fewer side effects than fluoxetine (P=0.01) (Advanced Biomedical Research, 2020).

Broader reviews of saffron for mood and related conditions describe it as generally safe and well tolerated at the doses studied (Avicenna Journal of Phytomedicine, 2022).

Reported side effects include:

• Nausea
• Dry mouth
• Drowsiness or dizziness
• Changes in appetite

These tend to ease on their own as your body adjusts. None of the trials behind this page reported serious harm at the doses used, though research in pregnancy, breastfeeding and in people under 18 is too thin to draw on.

For the fuller list, including rarer reactions and when to stop, see saffron side effects, including mood.

Saffron looks low-risk for most people in the trials so far, but a few groups need extra caution.

• If you're pregnant or trying to conceive, since saffron hasn't been tested for mood in pregnancy, and some forms affect the uterus.
• If you're already taking an SSRI or another medication that affects serotonin, since no trial has tested combining them.
• If you have a known allergy to saffron, iris or related plants.

Saffron still looks low-risk for most people. The caution above is for groups the research hasn't covered, so a quick conversation first is worth it if you fall into one of them.

Saffron doesn't have to stand alone. The treatments with the most consistent evidence for PMDD are SSRIs (sometimes taken only in the luteal phase), certain hormonal contraceptives, and CBT, and a doctor can help you weigh which fits (see PMDD treatment: what helps).

If you want to understand PMDD itself first, including how it's diagnosed and how it differs from PMS, start with PMDD (premenstrual dysphoric disorder), explained.

Niyora is a PMS and PMDD support app. If you want somewhere to put a hard moment while you wait to see whether saffron is helping, Niyora's Moon lets you write what happened, see it from another angle, and draft a reply you can hold onto for 20 minutes before you send anything.